Switzerland approves vaccine that targets two Covid variants
Moderna's new Covid-19 vaccine has been given temporary approval in Switzerland.
Copyright 2022 The Associated Press. All Rights Reserved
The Swiss medicaments regulator Swissmedic has given temporary approval for a Covid-19 vaccine from Moderna that has been adapted to give protection against two different strains of the virus.
This content was published on
1 minute
swissinfo.ch/mga
Español
es
Suiza aprueba vacuna contra dos variantes de COVID
The ‘Spikevax Bivalent Original/Omicron’ is designed to be administered in two 0.5ml doses.
It contains 25 micrograms of the original Spikevax mRNA-1273 plus 25 micrograms of a different mRNA that targets the Omicron variant (BA.1 and BA.4/5).
On Monday, Swissmedic saidExternal link that in trials the dual vaccine had achieved higher antibody concentrations against the Omicron variant than the original Spikevax, “with comparable side-effects”.
Those side-effects can include irritation, redness or swelling at the injection site, fatigue, headache, chills or nausea.
The Human Medicines Expert Committee has also given its separate seal of approval for the new vaccine, said Swissmedic.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss federal office sees no reason to end deportations of asylum-seekers to Croatia
This content was published on
Switzerland's State Secretariat for Migration (SEM) continues to deport asylum-seekers to Croatia. It thus rejects a demand from the Swiss Refugee Council in mid-February, which called for a halt to the returns.
ChatGPT responds to negative emotions and therapy, research shows
This content was published on
Stressful information can also cause anxiety in artificial intelligence (AI). As scientists in Zurich have shown, it's even possible to calm the GPT-4 AI model with mindfulness exercises.
Mortgage benchmark fall paves way for potential rent cuts in Switzerland
This content was published on
Switzerland’s national benchmark for mortgage costs dropped to the level it had before the global inflation surge, paving the way for potential rent reductions.
Switzerland ‘deeply concerned’ by Trump’s death penalty order
This content was published on
Switzerland has told the UN Human Rights Council that it is "deeply concerned" by US President Donald Trump's recent executive order to strengthen capital punishment at federal and state level.
Blatter, Platini return to court for new fraud trial over CHF2 million FIFA payment
This content was published on
Former FIFA President Sepp Blatter and former UEFA President Michel Platini appeared in court in Switzerland on Monday accused of fraud - 2.5 years after they were cleared.
Israel criticises Swiss decision to host Middle East conference in Geneva on Friday
This content was published on
Israel has condemned Switzerland for planning to host a meeting on international humanitarian law in the Middle East next Friday in Geneva.
Centre Party’s Franziska Biner elected to Valais government
This content was published on
Voters in canton Valais in southern Switzerland elected Franziska Biner to the cantonal government in the first round of voting, beating off more established politicians.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland gives green light to Moderna’s Covid vaccine for 6-11 year olds
This content was published on
The Swiss medical regulator Swissmedic has approved Moderna’s Spikevax Covid-19 vaccine for use by children aged 6 to 11 years.
Switzerland approves its first protein-based Covid vaccine
This content was published on
The Swiss medical regulator has approved the Nuvaxovid vaccine for adults making it the fourth Covid-19 vaccine authorised in the country.
Too many Covid doses: Switzerland’s vaccine conundrum
This content was published on
Switzerland is sitting on around 38 million excess Covid-19 vaccine doses to be used by the end of 2022. What will it do with them?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.